NASDAQ · Medical - Instruments & Supplies

Daxor Corporation (DXR) Stock

$10.71 +2.24% NASDAQ: DXR Healthcare

Based in Oak Ridge, Tennessee, Daxor Corporation is a medical technology enterprise founded in 1971. The company specializes in blood volume measurement, developing and commercializing the BVA-100 Blood Volume Analyzer.

Valuation

MetricValue
Price$10.71
Market Cap$53.94M
P/E Ratio5.90
P/B Ratio1.18
P/S Ratio359.13
EPS (TTM)$1.82
52-Week High$14.76
52-Week Low$8.56
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE22.50%
ROA19.93%
ROCE20.21%
Gross Margin-57.45%
Operating Margin900.00%
Net Margin900.00%
Debt/Equity0.00
Current Ratio0.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$-3.0M$0$35.0M$2.0M$1.0M
Operating Profit$5.0M$5.0M$0$1.0M$9.0M
Net Profit$5.0M$5.0M$0$1.0M$9.0M
EPS$1.18$0.60$0.06$0.11$1.84
Op Margin-181.6%-1485.9%0.9%29.2%1824.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$25.0M$30.0M$35.0M$37.0M$46.0M
Total Liabilities$4.0M$1.0M$1.0M$1.0M$0
Cash$1.0M$0$0$0$0
Borrowings$3.0M$1.0M$1.0M$1.0M$0

Latest News

Daxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas GlobeNewswire · Jul 7, 2026 Daxor Says Received US Patent for Remote Blood Volume Monitor Technology MT Newswires · Jun 2, 2026 Daxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitor GlobeNewswire · Jun 2, 2026 Daxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis GlobeNewswire · Apr 28, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-3.0M$-1.0M$-4.0M$0$-1.0M
Investing Cash Flow$0$3.0M$3.0M$2.0M$1.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$-1.0M$0$0$0
Free Cash Flow$-3.0M$-1.0M$-4.0M$0$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA5.66
FCF Yield0.31%
Quick Ratio0.00
Interest Coverage580.93
Return 1Y16.67%
Return 3Y9.51%
Return 5Y7.53%

Ownership

Insiders Held49.46%
Institutions Held6.56%
Institutions Float Held12.97%
Institutional HolderSharesReport Date
Thompson, Siegel & Walmsley LLC232,1202026-03-31
Vanguard Capital Management LLC48,2802026-03-31
Aristides Capital, LLC41,6922026-03-31
Renaissance Technologies, LLC28,0112026-03-31
Susquehanna International Group, LLP13,7202026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACET $8.30 +1.22% -0.46 $77.59M 0.00%
ADAGAdagene Inc. $3.67 +1.66% -7.78 $138.17M 0.00%
BEAT $0.50 +0.98% -1.48 $17.10M 0.00%
CRVO $2.56 -3.76% -1.09 $23.70M 0.00%
GANX $1.73 -6.99% -2.70 $73.79M 0.00%

About Daxor Corporation

Based in Oak Ridge, Tennessee, Daxor Corporation is a medical technology enterprise founded in 1971. The company specializes in blood volume measurement, developing and commercializing the BVA-100 Blood Volume Analyzer. This diagnostic instrument offers a precise, objective method for quantifying a patient's blood volume status and composition, comparing these metrics against their unique physiological norms. It is utilized across a wide spectrum of medical and surgical contexts. Prior to May 1973, the organization operated under the name Idant Corporation.

Daxor Corporation is headquartered in US.

Daxor Corporation (DXR) stock trades at $10.71 with a market capitalization of $53.94M. The stock is valued at a price-to-earnings (P/E) ratio of 5.90, price-to-book of 1.18, price-to-sales of 359.13. Over the past 52 weeks the stock has ranged between $8.56 and $14.76, and currently trades 27.4% below its 52-week high.

On profitability, Daxor Corporation generates a return on equity (ROE) of 22.50% — well above the market average, a sign of a high-quality business, return on capital employed of 20.21%, an operating margin of 900.00%, a net profit margin of 900.00%.

Official website: www.daxor.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides